Cellular Reprogramming toward the Erythroid Lineage
Haemoglobinopathies such as thalassaemia and sickle cell disease present a major health burden. Currently, the main forms of treatment for these diseases are packed red blood cell transfusions and the administration of drugs which act to nonspecifically reactivate the production of foetal haemoglobi...
Saved in:
Main Authors: | Laura J. Norton, Alister P. W. Funnell, Richard C. M. Pearson, Merlin Crossley |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | International Journal of Cell Biology |
Online Access: | http://dx.doi.org/10.1155/2011/501464 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PU.1 and Haematopoietic Cell Fate: Dosage Matters
by: Ka Sin Mak, et al.
Published: (2011-01-01) -
The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
by: Bharathi Suresh, et al.
Published: (2016-01-01) -
Reorganisation of chromatin during erythroid differentiation
by: A. A. Khabarova, et al.
Published: (2019-02-01) -
Uptake of Non-Transferrin Iron by Erythroid Cells
by: Eugenia Prus, et al.
Published: (2011-01-01) -
Cellular Programming and Reprogramming: Sculpting Cell Fate for the Production of Dopamine Neurons for Cell Therapy
by: Julio C. Aguila, et al.
Published: (2012-01-01)